Method of antiviral use of soluble LDL receptor

Details Method of antiviral use of soluble LDL receptor Method of antiviral use of soluble LDL receptor

1995-06-07

1998-03-03

Walsh, Stephen

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530350, 424545, A61K 3817, A07K 14705

Patent

active

057234388

ABSTRACT:
A soluble LDL receptor protein is provided. It can be isolated from cells that have been treated with an interferon, isolated from the urine of healthy human individuals or produced by recombinant techniques. The soluble LDL receptor protein is useful in protection of meals against viral infections.

REFERENCES:
patent: 4454115 (1984-06-01), Borden et al.
patent: 4614651 (1986-09-01), Jarvis et al.
patent: 4745060 (1988-05-01), Brown et al.
patent: 5208144 (1993-05-01), Smith et al.
Schneider et al., "Purification of the Low Density Lipoprotein Receptor, An Acidic Glycoprotein of 164,000 Molecular Weight", J. Biologial Chemistry 257:2664-2773 (1982).
Weil et al., Nature, vol. 301, p. 437, 1983.
Thomas et al., Methods in Enzymology, vol. 182, p. 499, 1990.
Spear, G. Journal of Virology Dec. 1990, vol. 64, No. 12 pp. 5869-5873.

Affiliated with

Also associated with

Rating

Method of antiviral use of soluble LDL receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of antiviral use of soluble LDL receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of antiviral use of soluble LDL receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2247700